Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 10751 - 10775 of 12317 in total

Broxuridine

Broxuridine has been used in trials studying the treatment of Leukemia, Stage I Prostate Cancer, Stage IIB Prostate Cancer, and Stage IIA Prostate Cancer.
Investigational
Matched Iupac: … 5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

MK-0893

MK0893 has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Diabetes Mellitus, Type 2.
Investigational
Matched Iupac: … 3-({4-[(1S)-1-[3-(3,5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl]phenyl}formamido …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Piclozotan

Piclozotan has been investigated for the treatment of Parkinson's Disease.
Investigational
Matched Iupac: … 3-chloro-4-(4-{1',2',3',6'-tetrahydro-[2,4'-bipyridine]-1'-yl}butyl)-4,5-dihydro-1,4-benzoxazepin-5-one …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Oxiracetam

Experimental
Matched Iupac: … 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Xanthohumol

Xanthohumol is under investigation in clinical trial NCT01367431 (Xanthohumol and Metabolic Syndrome).
Investigational
Matched Iupac: … (2E)-1-[2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Borneol

Experimental

2-Acetamido-2-Deoxy-D-Glucono-1,5-Lactone

Experimental
Matched Iupac: … N-[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-oxooxan-3-yl]acetamide …

PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE

Experimental
Matched Iupac: … 4-{[6-(2,6-dichlorobenzoyl)imidazo[1,2-a]pyridin-2-yl]amino}benzene-1-sulfonamide …

2-Amino-3-(Diethoxy-Phosphoryloxy)-Propionic Acid

Experimental
Matched Name: … 2-Amino-3-(Diethoxy-Phosphoryloxy)-Propionic Acid …
Matched Iupac: … (2S)-2-amino-3-[(diethoxyphosphoryl)oxy]propanoic acid …

HYDROXY[3-(6-METHYLPYRIDIN-2-YL)PROPYL]FORMAMIDE

Experimental
Matched Name: … HYDROXY[3-(6-METHYLPYRIDIN-2-YL)PROPYL]FORMAMIDE …
Matched Iupac: … N-hydroxy-N-[3-(6-methylpyridin-2-yl)propyl]formamide …

2-Amino-4-(Hydroxymethyl-Phosphinyl)Butanoic Acid

Experimental
Matched Name: … 2-Amino-4-(Hydroxymethyl-Phosphinyl)Butanoic Acid …
Matched Iupac: … (2R)-2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid …

5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE

Experimental

Ridogrel

Ridogrel is a dual action drug useful for the prevention of systemic thrombo-embolism and as an adjunctive agent to thrombolytic therapy in acute myocardial infarction. However, there currently are no clinical indications for preferential use of ridogrel over aspirin.
Experimental
Matched Iupac: … 5-{[(E)-[(pyridin-3-yl)[3-(trifluoromethyl)phenyl]methylidene]amino]oxy}pentanoic acid …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Siroheme

Experimental
Matched Iupac: … (24)-nonaen-4-yl]propanoic acid ... 3-[(1R,5S,10S)-9,15,19-tris(2-carboxyethyl)-5,10,14,20-tetrakis(carboxymethyl)-5,10-dimethyl-2,22,23,25 ... -tetraaza-1-ferraoctacyclo[11.9.1.1^{1,8}.1^{3,21}.0^{2,6}.0^{16,23}.0^{18,22}.0^{11,25}]pentacosa-3,6,8,11,13,15,17,19,21 …
Matched Categories: … Heterocyclic Compounds, 1-Ring ... Heterocyclic Compounds with 4 or More Rings …

Heme D

Experimental
Matched Iupac: … ferraoctacyclo[11.9.1.1^{1,8}.1^{3,21}.0^{2,6}.0^{16,23}.0^{18,22}.0^{11,25}]pentacosa-2(6),3(24),7,10,12,14,16,18,20 ... 15,19-bis(2-carboxyethyl)-4,9-bis(carboxymethyl)-4,9,14,20-tetramethyl-5-oxo-2lambda5,22,23,25-tetraaza-1- …
Matched Categories: … Heterocyclic Compounds, 1-Ring ... Heterocyclic Compounds with 4 or More Rings …

Lemuteporfin

Lemuteporfin, under development by QLT Incorporated, is a benzoporphyrin-derived chlorin-like photosensitizer. It is intended for the treatment of beign prostatic hyperplasia.
Investigational
Matched Iupac: … 20,21-dimethyl 5-ethenyl-10,14-bis[3-(2-hydroxyethoxy)-3-oxopropyl]-4,9,15,19-tetramethyl-25,26,27,28 ... -tetraazahexacyclo[16.6.1.1^{3,6}.1^{8,11}.1^{13,16}.0^{19,24}]octacosa-1,3(28),4,6,8,10,12,14,16(26) …
Matched Categories: … Heterocyclic Compounds, 1-Ring ... Heterocyclic Compounds with 4 or More Rings …

Rebastinib

Rebastinib has been used in trials studying the treatment of Chronic Myeloid Leukemia. It is an inhibitor of Tie2 tyrosine kinase receptor and an antineoplastic agent.
Investigational
Matched Iupac: … 4-[4-({[3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Talarozole

Talarozole has been investigated for the treatment of Psoriasis and Cutaneous Inflammation.
Investigational
Matched Iupac: … N-{4-[2-ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl}-1,3-benzothiazol-2-amine …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Pentetrazol

Pentetrazol, also known as pentylenetetrazole, is a gamma-aminobutyric acid type A (GABAA) receptor antagonist that was approved by the FDA until 1982.
Experimental
Withdrawn
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Bamipine

Experimental
Matched Iupac: … N-benzyl-1-methyl-N-phenylpiperidin-4-amine …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Metopimazine

Experimental
Matched Iupac: … 1-[3-(2-methanesulfonyl-10H-phenothiazin-10-yl)propyl]piperidine-4-carboxamide …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Enadoline

Investigational
Matched Iupac: … 2-(1-benzofuran-4-yl)-N-methyl-N-[(5R,7S,8S)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-yl]acetamide …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Allogeneic natural killer cells

Investigational

(5-hydroxyindolo[1,2-a]quinazolin-7-yl)acetic acid

Experimental

Bis(6-aminohexyl)amine

Experimental
Displaying drugs 10751 - 10775 of 12317 in total